# Amneal Pharmaceuticals, Llc (NASDAQ: AMRX), Paterson, NJ – FDA Inspections

Source: https://www.keypedia.com/companies/amneal-pharmaceuticals-llc/1727fcb2-2120-4a7c-a93b-a52aa106268f

> Inspection records and compliance data for Amneal Pharmaceuticals, Llc in Paterson, New Jersey. 6 FDA inspections on record, 1 Form 483, 1 warning letter, last inspected October 25, 2017. Publicly traded as NASDAQ: AMRX.

---

## Details

- Name: Amneal Pharmaceuticals, Llc
- FEI Number: 3003792057
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK
- Address Line 1: 209 McLean Blvd
- City: Paterson
- State: New Jersey
- Zip Code: 07504
- Country Name: United States
- Address: 209 McLean Blvd, Paterson, New Jersey 07504, United States
- Country: United States

## Stock

- Stock ticker: AMRX
- Exchange: NASDAQ
- Share price: $21.70
- Market cap: $7.6B
- Price as of: November 13, 2026

## Related Documents

- [WARNING_LETTER - Amneal Pharmaceuticals, Llc - 2025-03-19](https://www.keypedia.com/records/warning_letter/amneal-pharmaceuticals-llc/880c4a7d-44bc-4dca-af8a-f3e409f3c227) — source: FDA, date: March 19, 2025
- [FDA Inspection 1029733 - Amneal Pharmaceuticals, Llc - 2017-10-25](https://www.keypedia.com/records/fda_inspections/amneal-pharmaceuticals-llc/2f6c33c4-e553-4b5f-a644-195dc77102f7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 25, 2017
- FDA Inspection 989412 - Amneal Pharmaceuticals, Llc - 2016-10-13 — classification: No Action Indicated (NAI), source: FDA, date: October 13, 2016
- [FDA Inspection 854082 - Amneal Pharmaceuticals, Llc - 2013-11-13](https://www.keypedia.com/records/fda_inspections/amneal-pharmaceuticals-llc/89510723-8236-4dbc-961e-e31fa50956ed) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 13, 2013
- FDA Inspection 767064 - Amneal Pharmaceuticals, Llc - 2012-02-10 — classification: No Action Indicated (NAI), source: FDA, date: February 10, 2012
- [FDA Inspection 663872 - Amneal Pharmaceuticals, Llc - 2010-05-26](https://www.keypedia.com/records/fda_inspections/amneal-pharmaceuticals-llc/e50a0b9f-2563-407d-ac89-6dafc80e30eb) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 26, 2010
- [FDA Inspection 545906 - Amneal Pharmaceuticals, Llc - 2008-11-10](https://www.keypedia.com/records/fda_inspections/amneal-pharmaceuticals-llc/970591bd-3a60-4909-8bf8-121a2c6a7e9a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 10, 2008

## Related Companies

- [Ascend Laboratories, LLC](https://www.keypedia.com/companies/ascend-laboratories-llc/13da97c0-bcd0-4d01-9c02-8a46b089cfc5)
- [SC Johnson Professional USA, Inc.](https://www.keypedia.com/companies/sc-johnson-professional-usa-inc/e9b50d00-3095-4f01-9e05-4f21adc9812a)
- [Janssen Pharmaceuticals, dba Actelion Pharmaceutical](https://www.keypedia.com/companies/janssen-pharmaceuticals-dba-actelion-pharmaceutical/8d00c775-7a8c-41d5-aa2d-f2154459469d)
- [Rajinder S. Shiwach, M.D.](https://www.keypedia.com/companies/rajinder-s-shiwach-md/1c35f8c6-ef47-4802-b976-011300458fec)
- [Pharmacyclics LLC](https://www.keypedia.com/companies/pharmacyclics-llc/ac914c47-3023-4974-a8f2-6241d0db58b8)
- [Andrew C Sedillo, MD](https://www.keypedia.com/companies/andrew-c-sedillo-md/4d92fceb-05ed-4140-ab2f-36edf0630a9f)
- [Imaging Endpoints II, LLC.](https://www.keypedia.com/companies/imaging-endpoints-ii-llc/fcd4f5a9-856c-404f-b6f1-0fa2cb3c88f7)
- [Dario D. Altamirano, DO](https://www.keypedia.com/companies/dario-d-altamirano-do/3edb2aaf-26c5-417d-bd2a-35cb8d56cfc2)
- [Dakhil, Dr Shaker](https://www.keypedia.com/companies/dakhil-dr-shaker/ff880691-4af7-4e7b-ac3d-7c9c33c6bc2a)
- [Upsher-Smith Laboratories, LLC](https://www.keypedia.com/companies/upsher-smith-laboratories-llc/abe71588-9a29-43ec-9663-eabd373c78c5)

## Related Officers

- [Director](https://www.keypedia.com/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)